| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 799,2 M € | +5.0% | 761,1 M € | +6.0% | 718,3 M € | +8.0% | 664,9 M € | +5.6% | 630,0 M € | +13.3% | 555,9 M € | -9.1% | 611,2 M € | +10.9% | 551,0 M € | -1.2% | 558,0 M € | +15.7% | 482,2 M € | +11.0% | 434,3 M € | +3.1% | 421,4 M € | +5.7% | 398,5 M € | -1.5% | 404,6 M € | -4.6% | 424,0 M € | +6.4% | 398,5 M € | +17.4% | 339,5 M € | +9.3% | 310,5 M € | |
| EBITDA | 38,2 M € | -0.5% | 38,4 M € | -42.7% | 67,1 M € | +70.3% | 39,4 M € | -2.0% | 40,2 M € | -28.2% | 56,0 M € | +61.6% | 34,7 M € | +6.2% | 32,7 M € | -33.5% | 49,1 M € | +4.1% | 47,2 M € | -38.7% | 76,9 M € | +13609.3% | 561,3 k € | -98.4% | 36,2 M € | -5.6% | 38,3 M € | -24.2% | 50,5 M € | +11.2% | 45,5 M € | +13.5% | 40,0 M € | +13.4% | 35,3 M € | |
| Operating profit | 26,6 M € | +52.2% | 17,5 M € | -69.5% | 57,1 M € | +47.3% | 38,8 M € | +19.5% | 32,5 M € | -6.7% | 34,8 M € | +70.5% | 20,4 M € | +6.9% | 19,1 M € | -35.3% | 29,5 M € | -30.3% | 42,3 M € | -36.0% | 66,1 M € | +1093.0% | -6,7 M € | -128.5% | 23,4 M € | -22.4% | 30,2 M € | -19.4% | 37,4 M € | +13.1% | 33,0 M € | +19.7% | 27,6 M € | +17.2% | 23,6 M € | |
| Profit/loss | 12,1 M € | +149.0% | -24,7 M € | -154.6% | 45,2 M € | +6.1% | 42,6 M € | +10.4% | 38,5 M € | +58.3% | 24,4 M € | +38.6% | 17,6 M € | +24.5% | 14,1 M € | -45.2% | 25,8 M € | -35.3% | 39,8 M € | +6.3% | 37,5 M € | +2048.8% | 1,7 M € | -93.2% | 25,5 M € | -33.2% | 38,2 M € | +30.0% | 29,4 M € | -7.5% | 31,8 M € | -30.2% | 45,5 M € | +24.7% | 36,5 M € | |
| Equity | 590,9 M € | +28.8% | 458,8 M € | -5.1% | 483,4 M € | +0.2% | 482,3 M € | +9.7% | 439,7 M € | +5.7% | 416,2 M € | -8.5% | 454,9 M € | +4.0% | 437,5 M € | +3.3% | 423,4 M € | -10.4% | 472,6 M € | +9.3% | 432,6 M € | +6.1% | 407,6 M € | +0.4% | 405,9 M € | +1.4% | 400,4 M € | +4.8% | 382,2 M € | +5.3% | 362,8 M € | -0.8% | 365,6 M € | +4.6% | 349,4 M € | |
| Total assets | 979,9 M € | +13.6% | 862,4 M € | -0.0% | 862,5 M € | +12.3% | 767,7 M € | +2.4% | 749,6 M € | +2.2% | 733,2 M € | -2.9% | 755,0 M € | +1.5% | 744,0 M € | +10.2% | 675,2 M € | -4.9% | 709,9 M € | +13.7% | 624,3 M € | -1.6% | 634,5 M € | +8.3% | 585,7 M € | +6.2% | 551,7 M € | +3.7% | 532,3 M € | +4.7% | 508,5 M € | +3.2% | 492,6 M € | +5.9% | 465,3 M € | |
| Cash | 9,5 M € | +34.6% | 7,1 M € | -29.4% | 10,0 M € | -4.3% | 10,5 M € | +86.4% | 5,6 M € | -84.7% | 36,6 M € | +353.8% | 8,1 M € | -46.6% | 15,1 M € | -18.9% | 18,6 M € | -54.6% | 41,1 M € | -17.0% | 49,5 M € | -11.9% | 56,2 M € | +26.3% | 44,5 M € | +60.1% | 27,8 M € | +110.3% | 13,2 M € | -21.4% | 16,8 M € | +90.9% | 8,8 M € | -23.4% | 11,5 M € | |
| Debts | 362,3 M € | -3.2% | 374,2 M € | +3.9% | 360,2 M € | +33.4% | 269,9 M € | -5.2% | 284,6 M € | -2.7% | 292,7 M € | +6.9% | 273,8 M € | -3.6% | 284,0 M € | +24.9% | 227,3 M € | +9.2% | 208,2 M € | +33.2% | 156,3 M € | -4.8% | 164,3 M € | +2.6% | 160,1 M € | +23.0% | 130,2 M € | +0.1% | 130,0 M € | +1.2% | 128,5 M € | +11.8% | 114,9 M € | +8.3% | 106,1 M € | |
| Staff | 721,3 | 775,1 | 753,5 | 757,7 | 763,8 | 775 | 748,3 | 730,4 | 690,5 | 662,7 | 700,2 | 727,5 | 702,4 | 760,7 | 767,8 | 745 | 713,3 | 672 | ||||||||||||||||||
Public limited company · Leuven · incorporated on 05/05/1971 · 721,3 ETP
Public limited company profitable and well capitalised. Cash position rising (+34.6%).
Solid counterparty for a standard engagement.
TERUMO EUROPE is a Public limited company incorporated in 1971. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Leuven. It employs on average 721,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette